Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07132125 · ClinicalTrials.gov registry record · NA

Conversations With AI Chatbots Increase Short-Term Vaccine Intentions But Do Not Outperform Standard Public Health Messaging

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
930
Enrollment target

NCT07132125: Completed NA study, sponsored by University of Pennsylvania.

NCT07132125 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 930 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07132125, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
930 participants
Enrollment target

Study Summary

The goal of this clinical trial is to test whether short conversations with large language model (LLM) chatbots can persuade vaccine-hesitant parents to vaccinate their children against human papillomavirus (HPV). The study compares two chatbot styles to official public health information and to a no-message control. Parents of HPV-eligible children first complete a survey about their attitudes toward the HPV vaccine and their main concerns. They are then randomly assigned to read public health materials, have a three-minute conversation with either a default-style chatbot or a conversational-style chatbot tailored to their concern, or receive no message. The main outcome is change in intent to vaccinate immediately after the intervention, with follow-up surveys at 15 and 45 days.

Interventions

  • BEHAVIORAL Default-style LLM chatbot
  • BEHAVIORAL Conversational-style LLM chatbot
  • BEHAVIORAL Public health informational materials

Trial Details

FieldValue
Enrollment Target 930 participants
Start Date 2025-03-17
Est. Completion 2025-05-22
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT07132125

The ClinicalTrials.gov registry entry for NCT07132125 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 930 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Default-style LLM chatbot is the first listed.

NCT07132125 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07132125 about?

NCT07132125 is a clinical study titled "Conversations With AI Chatbots Increase Short-Term Vaccine Intentions But Do Not Outperform Standard Public Health Messaging". The goal of this clinical trial is to test whether short conversations with large language model (LLM) chatbots can persuade vaccine-hesitant parents to vaccinate their children against human papillomavirus (HPV). The study compares two chatbot styles to official public health information and to a n...

What is the current status of trial NCT07132125?

This trial is currently completed. It is a NA study. The enrollment target is 930 participants. The study started on 2025-03-17. Estimated completion is 2025-05-22.

What interventions are being tested in trial NCT07132125?

The interventions under investigation include: Default-style LLM chatbot (BEHAVIORAL), Conversational-style LLM chatbot (BEHAVIORAL), Public health informational materials (BEHAVIORAL).

Who is sponsoring clinical trial NCT07132125?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.